Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials
Authors
Maja Skov Kragsnæs (ORCID: https://orcid.org/0000-0001-9641-9065)
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials
Maja Skov Kragsnæs, Ghaith Bakdash, Benoît Gilbert, Martin Kriegel et al.
Journal
BMJ Open
Topics
Rheumatoid Arthritis Research and Therapies
article
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials
Maja Skov Kragsnæs, Ghaith Bakdash, Benoît Gilbert, Martin Kriegel, Axel Finckh, Mat Robinson, Karsten Kristiansen, C. Daïen, Robin Christensen, Francesco Ciccia, Peter Tugwell, Simone S. Li, Mario M. Zaiss, Julian Roberto Marchesi, José U. Scher, Benjamin H. Mullish, Kulveer Mankia, Torkell Ellingsen, Sebrina Maj-Britt Hansen, Daniele Mauro, Peter Holger Johnsen, Carlijn A. Wagenaar, Bjørk Khaliqi Sofíudóttir, Maxime Bréban, Jesús Miguéns Blanco, Anne‐Sophie Bergot, Niti Goel, Philip Rask Lage-Hansen, Christopher Rooney, Dennis McGonagle, Mine Orlu, Georg Andreas Schett, Gunnstein Bakland, Dirk Sw Elewaut, Émilie Dumas, Dirkjan van Schaadenburg
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(12)
Institutions
University of Geneva (CH), University of Copenhagen (DK), University Hospital of North Norway (NO), University of Leeds (GB), University of Chester (GB), Imperial College Healthcare NHS Trust (GB), Inserm (FR), The University of Queensland (AU), Duke University (US), University of Southern Denmark (DK), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Université de Versailles Saint-Quentin-en-Yvelines (FR), University of Campania "Luigi Vanvitelli" (IT), Université Paris-Saclay (FR), Leeds Teaching Hospitals NHS Trust (GB), Discovery Institute (US), Frederiksberg Hospital (DK), Ghent University Hospital (BE), Odense University Hospital (DK), Yale University (US), Universitätsklinikum Erlangen (DE), Centre Hospitalier Universitaire de Montpellier (FR), University Hospital Münster (DE), Amsterdam Neuroscience (NL), NIHR Leeds Musculoskeletal Biomedical Research Unit (GB), Hôpital Ambroise-Paré (FR), VIB-UGent Center for Inflammation Research (BE), Bruyère (CA), Clinique Ambroise Paré (FR), University College London (GB), Imperial College London (GB), New York University (US), University of Amsterdam (NL)
Funders
Lupus Research Alliance, UK Research and Innovation, Parker Institute for Cancer Immunotherapy, National Institute for Health and Care Research, Imperial College London, Imperial College Healthcare NHS Trust, Odense Universitetshospital, Syddansk Universitet, Medical Research Council, NIHR Imperial Biomedical Research Centre